CC
BCPC

Congruence Capital’s Balchem Corp BCPC Stock Holding History

Congruence Capital’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Sell
60,567
-27,091
-31% -$4.5M 2.67% 16
2026
Q1 		$14.9M Sell
87,658
-22,824
-21% -$3.88M 4.98% 9
2025
Q4 		$16.9M Buy
+110,482
New +$16.9M 6.23% 5

Other funds holding BCPC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Congruence Capital's BCPC Position: Q2 2026 in Review

Congruence Capital reduced its Balchem Corp (BCPC) stake by 31% in Q2 2026, selling an estimated $4.5M and leaving 60,567 shares worth $10.2M. The position accounts for 2.67% of the portfolio, ranked #16.

Congruence Capital first reported a position in BCPC in Q4 2025 and has held it in 3 quarters since. The position peaked at $16.9M in Q4 2025. 415 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

  • Congruence Capital held 60,567 shares of Balchem Corp worth $10.2M as of Q2 2026.
  • Congruence Capital sold 27,091 Balchem Corp shares in Q2 2026, an estimated $4.5M.
  • Balchem Corp made up 2.67% of Congruence Capital's portfolio in Q2 2026, its #16 holding.
  • Congruence Capital first reported a position in Balchem Corp in Q4 2025 and has held it in 3 quarters since.
  • Congruence Capital's Balchem Corp position peaked at $16.9M in Q4 2025.
  • 415 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on Congruence Capital's 13F filing for Q2 2026, filed 13 Aug 2026.